AAO News Archive
- Deal struck to develop integrin antagonist treatment
- New low-add multifocal IOLs yield higher patient satisfaction
- Regeneron, Bayer to develop AMD combination therapy
- FDA approves wide-field imaging system for newborns
- Brain mapping may someday lead to vision-restoring therapies
- FDA warns of loose safety seals on eye drops
- Stem cells regrow human lens, corneal tissue
Find an Eye MD near you!
- Details
Valeant Pharmaceuticals announced that it is cutting all ties with Philidor Rx, its consolidated specialty pharmacy business.
- Details
The European Commission approved aflibercept for visual impairment due to myopic choroidal neovascularization.
- Details
Allergan and Pfizer confirmed they are discussing a potential merger.
- Details
Novartis reports that profits fell 42% due largely to weak performance by its eye care division, Alcon.
- Details
The FDA has approved Zeimer’s femtosecond laser device
Read more: FDA approves laser for refractive and cataract surgery
- Details
The FDA has approved Zeimer’s femtosecond laser device.
Read more: FDA approves laser for refractive and cataract surgery